|
Market Cap (17-May) $54,392,152 (781st) |
Close (30-Jun) $0.250 |
Volume (30-Jun) 84,565 |
Shortsold (5-May) 9,746 (0.00%) (586th) |
|
52w High $0.59 |
52w Low $0.083 |
P/E 8.00 |
EPS -0.01 |
MDR released this announcement to the ASX on 25 October 2022, 8:59. The announcement is not marked as price sensitive, and is 1 page(s) in length and 61.21kb in size.
You can view all announcements from MDR and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDR was 0.017% short sold according to ASIC data. It was ranked the 606th most shorted stock on the ASX. It is now ranked as the 586th most shorted stock on the ASX with 0.002% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from MDR | |
|---|---|
| MDR undertakes strategic review | 22 June 2023, 9:51 |
| Initial Director's Interest Notice - Kate Hill | 29 May 2023, 11:05 |
| Initial Director's Interest Notice - Brett Magun | 29 May 2023, 11:00 |
| MedAdvisor September Quarterly (1Q FY23) Briefing | 25 October 2022, 8:59 |
| MDR appoints US health tech exec Kevin Hutchinson to Board | 19 October 2022, 14:28 |
| Application for quotation of securities - MDR | 18 October 2022, 15:54 |
| Application for quotation of securities - MDR | 13 October 2022, 16:53 |
You must be logged in to post a reply.
MedAdvisor 